Fluidigm Stock Price, News & Analysis (NASDAQ:FLDM)

$5.82 0.05 (0.87 %)
(As of 12/13/2017 04:00 PM ET)
Previous Close$5.77
Today's Range$5.75 - $5.93
52-Week Range$2.52 - $8.69
Volume58,189 shs
Average Volume253,310 shs
Market Capitalization$227.24 million
P/E RatioN/A
Dividend YieldN/A
Beta3.37

About Fluidigm (NASDAQ:FLDM)

Fluidigm logoFluidigm Corporation creates, manufactures and markets technologies and life science tools focused on the exploration and analysis of single cells, as well as the industrial application of genomics, based upon the Company's core microfluidics and mass cytometry technologies. The Company operates in the development, manufacturing and commercialization of life science tools for the life science and Ag-Bio industries segment. Its products include preparatory instruments, preparatory analytical instruments, analytical instruments, integrated fluidic circuits (IFCs), and assays and reagents. Its preparatory instruments include C1 Single-Cell Auto Prep System, Access Array System, Juno System and IFCs, and Callisto System and IFC. Its analytical instruments include Biomark HD System, EP1 System and Helios/CyTOF 2 System. Its assays and reagents include Delta Gene and SNP Type Assays, and Access Array Target-Specific Primers and Targeted Sequencing Prep Primers.

Receive FLDM News and Ratings via Email

Sign-up to receive the latest news and ratings for FLDM and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical Software & Technology Services
Sub-IndustryLife Sciences Tools & Services
SectorMedical
SymbolNASDAQ:FLDM
CUSIP34385P10
Phone650-266-6000

Debt

Debt-to-Equity Ratio5.00%
Current Ratio3.02%
Quick Ratio2.46%

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$104.45 million
Price / Sales2.15
Cash FlowN/A
Price / CashN/A
Book Value$1.83 per share
Price / Book3.18

Profitability

Trailing EPS($2.24)
Net Income$-75,980,000.00
Net Margins-68.27%
Return on Equity-134.35%
Return on Assets-17.77%

Miscellaneous

Employees589
Outstanding Shares38,650,000

Fluidigm (NASDAQ:FLDM) Frequently Asked Questions

What is Fluidigm's stock symbol?

Fluidigm trades on the NASDAQ under the ticker symbol "FLDM."

How were Fluidigm's earnings last quarter?

Fluidigm Co. (NASDAQ:FLDM) issued its earnings results on Thursday, August, 3rd. The medical research company reported ($0.58) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.60) by $0.02. The medical research company had revenue of $23.90 million for the quarter, compared to the consensus estimate of $23.50 million. Fluidigm had a negative return on equity of 134.35% and a negative net margin of 68.27%. The firm's quarterly revenue was down 15.2% on a year-over-year basis. During the same quarter last year, the company earned ($0.63) EPS. View Fluidigm's Earnings History.

When will Fluidigm make its next earnings announcement?

Fluidigm is scheduled to release their next quarterly earnings announcement on Wednesday, February, 14th 2018. View Earnings Estimates for Fluidigm.

Where is Fluidigm's stock going? Where will Fluidigm's stock price be in 2017?

1 Wall Street analysts have issued 12-month price targets for Fluidigm's shares. Their predictions range from $9.00 to $9.00. On average, they expect Fluidigm's stock price to reach $9.00 in the next twelve months. View Analyst Ratings for Fluidigm.

Who are some of Fluidigm's key competitors?

Who are Fluidigm's key executives?

Fluidigm's management team includes the folowing people:

  • Samuel D. Colella, Independent Chairman of the Board (Age 77)
  • Stephen Christopher Linthwaite, President, Chief Executive Officer, Chief Operating Officer, Director (Age 45)
  • Vikram Jog, Chief Financial Officer (Age 59)
  • William Maxwell Smith J.D., Executive Vice President - Legal Affairs, General Counsel, Secretary (Age 65)
  • Robert C. Jones, Executive Vice President - Research and Development (Age 60)
  • Jennifer Ling Lee, Principal Accounting Officer, Vice President, Controller (Age 53)
  • Mai Chan Yow, Executive Vice President - Worldwide Manufacturing and Managing Director (Age 56)
  • Nicolas M. Barthelemy, Director (Age 51)
  • Carlos V. Paya M.D., Ph.D., Director (Age 58)
  • Gerhard F. Burbach, Independent Director (Age 53)

Who owns Fluidigm stock?

Fluidigm's stock is owned by many different of retail and institutional investors. Top institutional shareholders include Neuberger Berman Group LLC (13.49%), Russell Investments Group Ltd. (11.72%), Bank of New York Mellon Corp (1.26%), Fuller & Thaler Asset Management Inc. (1.04%), Wasatch Advisors Inc. (0.86%) and Dimensional Fund Advisors LP (0.28%). Company insiders that own Fluidigm stock include Evan/ Fa Jones, Levin Capital Strategies, LP, Samuel D Colella, Stephen Christopher Linthwaite and Steven Mcphail. View Institutional Ownership Trends for Fluidigm.

Who sold Fluidigm stock? Who is selling Fluidigm stock?

Fluidigm's stock was sold by a variety of institutional investors in the last quarter, including Wasatch Advisors Inc., JPMorgan Chase & Co. and Dimensional Fund Advisors LP. View Insider Buying and Selling for Fluidigm.

Who bought Fluidigm stock? Who is buying Fluidigm stock?

Fluidigm's stock was bought by a variety of institutional investors in the last quarter, including Neuberger Berman Group LLC, Russell Investments Group Ltd., Bank of New York Mellon Corp, Dynamic Technology Lab Private Ltd, Fuller & Thaler Asset Management Inc., Group One Trading L.P. and Sei Investments Co.. Company insiders that have bought Fluidigm stock in the last two years include Levin Capital Strategies, LP, Samuel D Colella, Stephen Christopher Linthwaite and Steven Mcphail. View Insider Buying and Selling for Fluidigm.

How do I buy Fluidigm stock?

Shares of Fluidigm can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Fluidigm's stock price today?

One share of Fluidigm stock can currently be purchased for approximately $5.82.

How big of a company is Fluidigm?

Fluidigm has a market capitalization of $227.24 million and generates $104.45 million in revenue each year. The medical research company earns $-75,980,000.00 in net income (profit) each year or ($2.24) on an earnings per share basis. Fluidigm employs 589 workers across the globe.

How can I contact Fluidigm?

Fluidigm's mailing address is 7000 Shoreline Court Suite 100, South San Francisco CA, 94080. The medical research company can be reached via phone at 650-266-6000.


MarketBeat Community Rating for Fluidigm (FLDM)

Community Ranking:  3.2 out of 5 (star star star)
Outperform Votes:  297 (Vote Outperform)
Underperform Votes:  165 (Vote Underperform)
Total Votes:  462
MarketBeat's community ratings are surveys of what our community members think about Fluidigm and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Fluidigm (NASDAQ:FLDM) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.002.83
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $10.50$10.50$12.00$14.60
Price Target Upside: 68.81% upside68.81% upside92.93% upside134.73% upside

Fluidigm (NASDAQ:FLDM) Consensus Price Target History

Price Target History for Fluidigm (NASDAQ:FLDM)

Fluidigm (NASDAQ:FLDM) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
2/9/2017Cantor FitzgeraldSet Price TargetBuy$9.00N/AView Rating Details
8/5/2016MizuhoBoost Price TargetBuy$11.00 -> $12.00N/AView Rating Details
6/1/2016Deutsche BankInitiated CoverageBuyN/AView Rating Details
4/12/2016Leerink SwannLower Price TargetOutperform$20.00 -> $15.00N/AView Rating Details
1/20/2016CowenReiterated RatingOutperform -> Market PerformN/AView Rating Details
1/6/2016Avondale PartnersInitiated CoverageOutperform$20.00N/AView Rating Details
(Data available from 12/13/2015 forward)

Earnings

Fluidigm (NASDAQ:FLDM) Earnings History and Estimates Chart

Earnings by Quarter for Fluidigm (NASDAQ:FLDM)

Fluidigm (NASDAQ FLDM) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/6/2018N/AView Earnings Details
8/3/2017Q2 2017($0.60)($0.58)$23.50 million$23.90 millionViewListenView Earnings Details
2/8/2017Q4 2016($0.61)($0.61)$25.91 million$25.10 millionViewListenView Earnings Details
11/3/2016Q3($0.67)($0.68)$27.75 million$22.20 millionViewN/AView Earnings Details
8/4/2016Q2($0.58)($0.64)$29.62 million$28.20 millionViewN/AView Earnings Details
5/5/2016Q116($0.53)($0.40)$26.95 million$29.00 millionViewN/AView Earnings Details
10/29/2015Q315($0.55)($0.15)$27.54 million$28.60 millionViewListenView Earnings Details
8/6/2015Q215($0.48)($0.53)$30.43 million$28.62 millionViewListenView Earnings Details
5/7/2015Q115($0.40)($0.39)$30.70 million$26.70 millionViewListenView Earnings Details
2/5/2015Q414($0.43)($0.39)$33.34 million$33.50 millionViewListenView Earnings Details
10/30/2014Q314($0.04)($0.49)$29.20 million$29.60 millionViewN/AView Earnings Details
7/31/2014Q214($0.50)($0.45)$27.13 million$27.60 millionViewN/AView Earnings Details
2/6/2014Q413($0.15)($0.04)$20.73 million$20.90 millionViewN/AView Earnings Details
10/30/2013Q313($0.20)($0.06)$16.70 million$18.30 millionViewN/AView Earnings Details
8/1/2013Q2 2013($0.17)($0.07)$15.87 million$17.50 millionViewN/AView Earnings Details
11/7/2012Q312($0.21)($0.12)$13.35 million$12.60 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Fluidigm (NASDAQ:FLDM) Earnings Estimates

Current Year EPS Consensus Estimate: $-1.4 EPS
Next Year EPS Consensus Estimate: $-0.7 EPS

Dividends

Dividend History for Fluidigm (NASDAQ:FLDM)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Fluidigm (NASDAQ FLDM) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 4.70%
Institutional Ownership Percentage: 93.33%
Insider Trades by Quarter for Fluidigm (NASDAQ:FLDM)
Institutional Ownership by Quarter for Fluidigm (NASDAQ:FLDM)

Fluidigm (NASDAQ FLDM) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
12/12/2017Levin Capital Strategies, L.P.InsiderBuy18,569$5.84$108,442.96View SEC Filing  
12/4/2017Levin Capital Strategies, L.P.InsiderBuy8,409$5.48$46,081.32View SEC Filing  
11/29/2017Levin Capital Strategies, L.P.InsiderBuy20,380$5.71$116,369.80View SEC Filing  
11/17/2017Levin Capital Strategies, L.P.InsiderBuy6,880$5.05$34,744.00View SEC Filing  
11/8/2017Levin Capital Strategies, L.P.InsiderBuy54,900$5.26$288,774.00View SEC Filing  
10/25/2017Levin Capital Strategies, L.P.InsiderBuy4,227$5.42$22,910.34View SEC Filing  
10/23/2017Levin Capital Strategies, L.P.InsiderBuy22,363$5.47$122,325.61View SEC Filing  
10/19/2017Levin Capital Strategies, L.P.InsiderBuy60,000$4.55$273,000.00View SEC Filing  
10/17/2017Levin Capital Strategies, L.P.InsiderBuy144,200$4.59$661,878.00View SEC Filing  
10/10/2017Levin Capital Strategies, L.P.InsiderBuy95,843$4.57$438,002.51View SEC Filing  
10/9/2017Levin Capital Strategies, L.P.InsiderBuy50,000$4.59$229,500.00View SEC Filing  
9/12/2017Levin Capital Strategies, L.P.InsiderBuy60,000$5.25$315,000.00View SEC Filing  
8/17/2017Levin Capital Strategies, L.P.InsiderBuy465$3.66$1,701.90View SEC Filing  
8/10/2017Levin Capital Strategies, L.P.InsiderBuy4,003,129$3.30$13,210,325.70View SEC Filing  
8/9/2017Levin Capital Strategies, L.P.InsiderBuy1,549$3.18$4,925.82View SEC Filing  
8/8/2017Samuel D ColellaDirectorBuy35,895$2.77$99,429.15View SEC Filing  
8/8/2017Stephen Christopher LinthwaiteCEOBuy45,000$2.66$119,700.00View SEC Filing  
8/8/2017Steven McphailInsiderBuy20,000$3.00$60,000.00View SEC Filing  
6/7/2017Evan/ Fa JonesDirectorSell10,900$4.54$49,486.00View SEC Filing  
5/9/2017Samuel D ColellaDirectorBuy7,500$5.93$44,475.00View SEC Filing  
3/14/2017Samuel D ColellaDirectorBuy10,000$5.00$50,000.00View SEC Filing  
12/14/2016Samuel D ColellaDirectorBuy5,000$7.39$36,950.00View SEC Filing  
11/30/2016Samuel D ColellaDirectorBuy20,000$6.32$126,400.00View SEC Filing  
11/30/2016Stephen Christopher LinthwaiteCEOBuy55,000$6.36$349,800.00View SEC Filing  
11/7/2016Levin Capital Strategies, L.P.InsiderBuy159,200$4.44$706,848.00View SEC Filing  
11/2/2016Levin Capital Strategies, L.P.InsiderBuy48,302$4.44$214,460.88View SEC Filing  
10/1/2015Gajus Vincent WorthingtonCEOSell6,000$8.05$48,300.00View SEC Filing  
9/2/2015Gajus Vincent WorthingtonCEOSell12,000$11.53$138,360.00View SEC Filing  
6/16/2015Vikram JogCFOSell3,550$25.00$88,750.00View SEC Filing  
6/15/2015William Maxwell SmithEVPSell3,000$24.20$72,600.00View SEC Filing  
6/1/2015Gajus Vincent WorthingtonCEOSell6,000$23.71$142,260.00View SEC Filing  
4/20/2015Mai Chan YowInsiderSell15,300$44.73$684,369.00View SEC Filing  
4/17/2015Mai Chan YowInsiderSell4,700$44.04$206,988.00View SEC Filing  
4/17/2015William Maxwell SmithEVPSell3,000$43.05$129,150.00View SEC Filing  
4/8/2015Mai Chan YowInsiderSell30,000$42.67$1,280,100.00View SEC Filing  
4/7/2015Vikram JogCFOSell3,950$40.81$161,199.50View SEC Filing  
4/1/2015Gajus Vincent WorthingtonCEOSell6,000$40.02$240,120.00View SEC Filing  
4/1/2015Robert C JonesEVPSell3,000$41.63$124,890.00View SEC Filing  
3/16/2015William Maxwell SmithEVPSell3,000$40.87$122,610.00View SEC Filing  
3/9/2015Vikram JogCFOSell3,950$41.48$163,846.00View SEC Filing  
3/2/2015Evan/ Fa JonesDirectorSell7,500$44.15$331,125.00View SEC Filing  
3/2/2015Gajus Vincent WorthingtonCEOSell6,000$43.77$262,620.00View SEC Filing  
3/2/2015Robert C JonesEVPSell3,000$43.78$131,340.00View SEC Filing  
2/20/2015Samuel D ColellaDirectorSell44,540$38.97$1,735,723.80View SEC Filing  
2/2/2015Gajus Vincent WorthingtonCEOSell6,000$38.15$228,900.00View SEC Filing  
1/15/2015William Maxwell SmithEVPSell3,000$34.24$102,720.00View SEC Filing  
1/2/2015Gajus Vincent WorthingtonCEOSell6,000$33.37$200,220.00View SEC Filing  
12/15/2014William Maxwell SmithEVPSell3,000$27.20$81,600.00View SEC Filing  
12/12/2014Evan/ Fa JonesDirectorSell8,352$27.44$229,178.88View SEC Filing  
12/9/2014Evan/ Fa JonesDirectorSell3,336$28.34$94,542.24View SEC Filing  
12/8/2014Evan/ Fa JonesDirectorSell1,000$29.06$29,060.00View SEC Filing  
12/8/2014Vikram JogCFOSell3,950$29.07$114,826.50View SEC Filing  
12/1/2014Gajus Vincent WorthingtonCEOSell6,000$30.03$180,180.00View SEC Filing  
11/17/2014William Maxwell SmithEVPSell3,000$29.52$88,560.00View SEC Filing  
11/12/2014Evan/ Fa JonesDirectorSell5,000$29.55$147,750.00View SEC Filing  
11/7/2014Vikram JogCFOSell3,950$29.45$116,327.50View SEC Filing  
10/24/2014Mai Chan YowInsiderSell10,000$28.00$280,000.00View SEC Filing  
10/7/2014Vikram JogCFOSell3,950$22.65$89,467.50View SEC Filing  
9/15/2014William Maxwell SmithEVPSell3,000$30.83$92,490.00View SEC Filing  
9/8/2014Vikram JogCFOSell3,950$28.57$112,851.50View SEC Filing  
9/2/2014Gajus Vincent WorthingtonCEOSell6,000$28.16$168,960.00View SEC Filing  
8/7/2014Vikram JogCFOSell3,733$26.34$98,327.22View SEC Filing  
8/6/2014Gajus Vincent WorthingtonCEOSell6,000$26.53$159,180.00View SEC Filing  
7/15/2014William Maxwell SmithEVPSell3,000$31.98$95,940.00View SEC Filing  
7/7/2014Vikram JogCFOSell5,427$30.61$166,120.47View SEC Filing  
7/1/2014Gajus Vincent WorthingtonCEOSell6,000$29.72$178,320.00View SEC Filing  
6/16/2014William Maxwell SmithEVPSell3,000$27.64$82,920.00View SEC Filing  
6/2/2014Gajus Vincent WorthingtonCEOSell6,000$26.55$159,300.00View SEC Filing  
5/15/2014William Maxwell SmithEVPSell3,000$28.53$85,590.00View SEC Filing  
5/8/2014Gajus Vincent WorthingtonCEOSell6,000$32.14$192,840.00View SEC Filing  
4/15/2014William Maxwell SmithEVPSell3,000$35.32$105,960.00View SEC Filing  
4/7/2014Vikram JogCFOSell5,091$37.51$190,963.41View SEC Filing  
3/17/2014William Maxwell SmithEVPSell3,000$47.76$143,280.00View SEC Filing  
11/6/2013Gajus Vincent WorthingtonCEOSell11,832$30.03$355,314.96View SEC Filing  
9/3/2013Gajus Vincent WorthingtonCEOSell10,000$20.53$205,300.00View SEC Filing  
9/3/2013William Maxwell SmithEVPSell7,000$20.42$142,940.00View SEC Filing  
8/30/2013Robert JonesEVPSell3,500$20.36$71,260.00View SEC Filing  
8/14/2013Samuel ColellaDirectorSell23,192$19.91$461,752.72View SEC Filing  
8/8/2013William Maxwell SmithEVPSell16,000$20.02$320,320.00View SEC Filing  
8/6/2013Gajus Vincent WorthingtonCEOSell10,000$19.49$194,900.00View SEC Filing  
8/6/2013Robert JonesEVPSell3,500$19.16$67,060.00View SEC Filing  
7/8/2013Vikram JogCFOSell5,661$17.05$96,520.05View SEC Filing  
7/1/2013Gajus Vincent WorthingtonCEOSell10,000$17.14$171,400.00View SEC Filing  
7/1/2013William Maxwell SmithEVPSell5,000$17.11$85,550.00View SEC Filing  
6/28/2013Robert C JonesEVPSell3,500$17.11$59,885.00View SEC Filing  
6/7/2013Vikram JogCFOSell5,661$16.00$90,576.00View SEC Filing  
6/3/2013Gajus Vincent WorthingtonCEOSell10,000$17.00$170,000.00View SEC Filing  
6/3/2013William Maxwell SmithInsiderSell5,000$16.96$84,800.00View SEC Filing  
5/31/2013Robert C JonesEVPSell3,500$16.93$59,255.00View SEC Filing  
3/4/2013Mai Chan YowInsiderSell30,000$18.15$544,500.00View SEC Filing  
2/4/2013Robert C JonesEVPSell6,984$16.61$116,004.24View SEC Filing  
2/1/2013Gajus Vincent WorthingtonCEOSell10,000$16.60$166,000.00View SEC Filing  
12/28/2012William Maxwell SmithInsiderSell4,504$14.11$63,551.44View SEC Filing  
12/26/2012William Maxwell SmithInsiderSell6,756$14.36$97,016.16View SEC Filing  
12/14/2012Evan/ Fa JonesDirectorBuy10,000$14.36$143,600.00View SEC Filing  
12/11/2012Evan/ Fa JonesDirectorBuy1,971$14.00$27,594.00View SEC Filing  
12/5/2012William Maxwell SmithEVPSell6,756$14.25$96,273.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Fluidigm (NASDAQ FLDM) News Headlines

Source:
DateHeadline
ETFs with exposure to Fluidigm Corp. : December 7, 2017ETFs with exposure to Fluidigm Corp. : December 7, 2017
finance.yahoo.com - December 7 at 5:10 PM
Insider Buying: Fluidigm Co. (FLDM) Insider Buys 8,409 Shares of StockInsider Buying: Fluidigm Co. (FLDM) Insider Buys 8,409 Shares of Stock
www.americanbankingnews.com - December 6 at 2:40 PM
Cotiviti (COTV) & Fluidigm (FLDM) Critical ContrastCotiviti (COTV) & Fluidigm (FLDM) Critical Contrast
www.americanbankingnews.com - December 6 at 7:36 AM
Fluidigm (FLDM) versus Castlight Health (CSLT) Head to Head ReviewFluidigm (FLDM) versus Castlight Health (CSLT) Head to Head Review
www.americanbankingnews.com - December 3 at 9:48 PM
Greenway Health (GWAY) and Fluidigm (FLDM) Head-To-Head ReviewGreenway Health (GWAY) and Fluidigm (FLDM) Head-To-Head Review
www.americanbankingnews.com - December 2 at 1:50 AM
Fluidigm Corporation (FLDM) Insider Buys $116,369.80 in StockFluidigm Corporation (FLDM) Insider Buys $116,369.80 in Stock
www.americanbankingnews.com - November 30 at 8:44 PM
ETFs with exposure to Fluidigm Corp. : November 27, 2017ETFs with exposure to Fluidigm Corp. : November 27, 2017
finance.yahoo.com - November 27 at 5:48 PM
Complete Genomics (GNOM) versus Fluidigm Corporation (FLDM) Critical AnalysisComplete Genomics (GNOM) versus Fluidigm Corporation (FLDM) Critical Analysis
www.americanbankingnews.com - November 25 at 11:32 AM
Insider Buying: Fluidigm Corporation (FLDM) Insider Purchases 6,880 Shares of StockInsider Buying: Fluidigm Corporation (FLDM) Insider Purchases 6,880 Shares of Stock
www.americanbankingnews.com - November 21 at 9:34 PM
Fluidigm Corp. :FLDM-US: Earnings Analysis: Q3, 2017 By the Numbers : November 21, 2017Fluidigm Corp. :FLDM-US: Earnings Analysis: Q3, 2017 By the Numbers : November 21, 2017
finance.yahoo.com - November 21 at 6:51 PM
Fluidigm to Participate in the 29th Annual Piper Jaffray Healthcare ConferenceFluidigm to Participate in the 29th Annual Piper Jaffray Healthcare Conference
finance.yahoo.com - November 14 at 7:07 PM
Fluidigm Corporation (FLDM) Lowered to "Strong Sell" at ValuEngineFluidigm Corporation (FLDM) Lowered to "Strong Sell" at ValuEngine
www.americanbankingnews.com - November 10 at 12:58 AM
Fluidigm Corporation (FLDM) Insider Levin Capital Strategies, L.P. Purchases 54,900 SharesFluidigm Corporation (FLDM) Insider Levin Capital Strategies, L.P. Purchases 54,900 Shares
www.americanbankingnews.com - November 9 at 3:28 PM
Edited Transcript of FLDM earnings conference call or presentation 2-Nov-17 9:00pm GMTEdited Transcript of FLDM earnings conference call or presentation 2-Nov-17 9:00pm GMT
finance.yahoo.com - November 3 at 12:17 PM
Fluidigm Corporation to Host Earnings CallFluidigm Corporation to Host Earnings Call
finance.yahoo.com - November 2 at 8:00 PM
Fluidigm Announces Third Quarter Financial Results and Operational ProgressFluidigm Announces Third Quarter Financial Results and Operational Progress
finance.yahoo.com - November 2 at 8:00 PM
Fluidigm reports 3Q lossFluidigm reports 3Q loss
finance.yahoo.com - November 2 at 8:00 PM
Does Fluidigm Corporation’s (FLDM) Debt Level Pose A Serious Problem?Does Fluidigm Corporation’s (FLDM) Debt Level Pose A Serious Problem?
finance.yahoo.com - November 1 at 12:51 AM
Levin Capital Strategies, L.P. Buys 4,227 Shares of Fluidigm Corporation (FLDM) StockLevin Capital Strategies, L.P. Buys 4,227 Shares of Fluidigm Corporation (FLDM) Stock
www.americanbankingnews.com - October 27 at 9:02 PM
Fluidigm Corporation (FLDM) to Release Earnings on ThursdayFluidigm Corporation (FLDM) to Release Earnings on Thursday
www.americanbankingnews.com - October 26 at 6:10 AM
ETFs with exposure to Fluidigm Corp. : October 25, 2017ETFs with exposure to Fluidigm Corp. : October 25, 2017
finance.yahoo.com - October 25 at 10:30 PM
Fluidigm Introduces Imaging Mass Cytometry System for Highly Multiplexed Protein Detection in TissuesFluidigm Introduces Imaging Mass Cytometry System for Highly Multiplexed Protein Detection in Tissues
finance.yahoo.com - October 25 at 12:02 AM
Fluidigm Announces Agreement With the University of Zurich to Distribute histoCAT for Multiparameter Imaging Mass Cytometry Data AnalysisFluidigm Announces Agreement With the University of Zurich to Distribute histoCAT for Multiparameter Imaging Mass Cytometry Data Analysis
finance.yahoo.com - October 25 at 12:02 AM
Levin Capital Strategies, L.P. Purchases 22,363 Shares of Fluidigm Corporation (FLDM) StockLevin Capital Strategies, L.P. Purchases 22,363 Shares of Fluidigm Corporation (FLDM) Stock
www.americanbankingnews.com - October 24 at 4:14 PM
Insider Buying: Fluidigm Corporation (FLDM) Insider Acquires 60,000 Shares of StockInsider Buying: Fluidigm Corporation (FLDM) Insider Acquires 60,000 Shares of Stock
www.americanbankingnews.com - October 23 at 7:28 PM
Levin Capital Strategies, L.P. Buys 144,200 Shares of Fluidigm Corporation (FLDM) StockLevin Capital Strategies, L.P. Buys 144,200 Shares of Fluidigm Corporation (FLDM) Stock
www.americanbankingnews.com - October 23 at 1:32 PM
Fluidigm to Report Q3 2017 Financial Results and Host Conference CallFluidigm to Report Q3 2017 Financial Results and Host Conference Call
finance.yahoo.com - October 19 at 7:25 PM
Fluidigm to Unveil High-Parameter Tissue Imaging SystemFluidigm to Unveil High-Parameter Tissue Imaging System
finance.yahoo.com - October 18 at 8:06 PM
athenahealth (ATHN) vs. Fluidigm Corporation (FLDM) Critical Reviewathenahealth (ATHN) vs. Fluidigm Corporation (FLDM) Critical Review
www.americanbankingnews.com - October 12 at 6:46 AM
ETFs with exposure to Fluidigm Corp. : October 11, 2017ETFs with exposure to Fluidigm Corp. : October 11, 2017
finance.yahoo.com - October 11 at 8:18 PM
Fluidigm Corporation (FLDM) Insider Purchases $229,500.00 in StockFluidigm Corporation (FLDM) Insider Purchases $229,500.00 in Stock
www.americanbankingnews.com - October 11 at 7:52 PM
Insider Buying: Fluidigm Corporation (FLDM) Insider Acquires 95,843 Shares of StockInsider Buying: Fluidigm Corporation (FLDM) Insider Acquires 95,843 Shares of Stock
www.americanbankingnews.com - October 11 at 7:50 PM
Analyzing Fluidigm Corporation (FLDM) and Its RivalsAnalyzing Fluidigm Corporation (FLDM) and Its Rivals
www.americanbankingnews.com - October 9 at 6:28 PM
Head-To-Head Comparison: Fluidigm Corporation (FLDM) vs. Its RivalsHead-To-Head Comparison: Fluidigm Corporation (FLDM) vs. Its Rivals
www.americanbankingnews.com - October 5 at 6:24 PM
Should You Be Concerned About Fluidigm Corporation’s (FLDM) Risks?Should You Be Concerned About Fluidigm Corporation’s (FLDM) Risks?
finance.yahoo.com - October 2 at 2:33 PM
Contrasting Fluidigm Corporation (FLDM) and Simulations Plus (SLP)Contrasting Fluidigm Corporation (FLDM) and Simulations Plus (SLP)
www.americanbankingnews.com - September 30 at 4:20 PM
Financial Review: Fluidigm Corporation (FLDM) vs. The CompetitionFinancial Review: Fluidigm Corporation (FLDM) vs. The Competition
www.americanbankingnews.com - September 26 at 2:08 PM
Reviewing Fluidigm Corporation (FLDM) & Its RivalsReviewing Fluidigm Corporation (FLDM) & Its Rivals
www.americanbankingnews.com - September 25 at 12:26 AM
Reviewing Fluidigm Corporation (FLDM) and Its RivalsReviewing Fluidigm Corporation (FLDM) and Its Rivals
www.americanbankingnews.com - September 24 at 8:12 PM
Analyzing Fluidigm Corporation (FLDM) & athenahealth (ATHN)Analyzing Fluidigm Corporation (FLDM) & athenahealth (ATHN)
www.americanbankingnews.com - September 23 at 4:22 AM
Veeva Systems (VEEV) vs. Fluidigm Corporation (FLDM) Critical ComparisonVeeva Systems (VEEV) vs. Fluidigm Corporation (FLDM) Critical Comparison
www.americanbankingnews.com - September 20 at 12:36 AM
Fluidigm Corporation (FLDM) vs. Its Competitors Head-To-Head ContrastFluidigm Corporation (FLDM) vs. Its Competitors Head-To-Head Contrast
www.americanbankingnews.com - September 18 at 6:24 PM
Insider Buying: Fluidigm Corporation (FLDM) Insider Buys 60,000 Shares of StockInsider Buying: Fluidigm Corporation (FLDM) Insider Buys 60,000 Shares of Stock
www.americanbankingnews.com - September 14 at 11:16 PM
Financial Comparison: Fluidigm Corporation (FLDM) and its RivalsFinancial Comparison: Fluidigm Corporation (FLDM) and its Rivals
www.americanbankingnews.com - September 11 at 4:22 AM
Financial Contrast: Omnicell (OMCL) vs. Fluidigm Corporation (FLDM)Financial Contrast: Omnicell (OMCL) vs. Fluidigm Corporation (FLDM)
www.americanbankingnews.com - September 8 at 6:10 AM
Fluidigm to Participate in Two Upcoming Health Care Conferences in SeptemberFluidigm to Participate in Two Upcoming Health Care Conferences in September
finance.yahoo.com - August 28 at 6:24 PM
Short Interest in Fluidigm Corporation (FLDM) Expands By 67.9%Short Interest in Fluidigm Corporation (FLDM) Expands By 67.9%
www.americanbankingnews.com - August 28 at 1:48 AM
ETFs with exposure to Fluidigm Corp. : August 25, 2017ETFs with exposure to Fluidigm Corp. : August 25, 2017
finance.yahoo.com - August 26 at 1:09 AM
Fluidigm Licenses CFTR Next-Generation Sequencing Assay From Baylor Genetics for Use With the Juno SystemFluidigm Licenses CFTR Next-Generation Sequencing Assay From Baylor Genetics for Use With the Juno System
finance.yahoo.com - August 17 at 7:56 PM
Fluidigm Corp. :FLDM-US: Earnings Analysis: Q2, 2017 By the Numbers : August 16, 2017Fluidigm Corp. :FLDM-US: Earnings Analysis: Q2, 2017 By the Numbers : August 16, 2017
finance.yahoo.com - August 16 at 6:46 PM

SEC Filings

Fluidigm (NASDAQ:FLDM) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Fluidigm (NASDAQ:FLDM) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Fluidigm (NASDAQ FLDM) Stock Chart for Wednesday, December, 13, 2017

Loading chart…

This page was last updated on 12/13/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.